Table 1 Physical health conditions associated with fragile X syndrome (FXS).
FXS (n = 55) | Controls (n = 5,500) | ||||
|---|---|---|---|---|---|
Description | Prevalence (percentage) | Average encounters | Prevalence (percentage) | Average encounters | P value (encounters) |
Circulatory | |||||
Heart valve replaced | 3.64 | 14 | 0.13 | 11 | 4.01E-11 |
First degree atrioventricular (AV) block | 5.45 | 3.33 | 0.13 | 4.14 | 7.71E-11 |
Heart valve disorders | 9.09 | 25.4 | 1.85 | 12.5 | 6.29E-07 |
Rheumatic disease of the heart valves | 7.27 | 5.5 | 0.6 | 5.45 | 2.76E-06 |
Digestive | |||||
Dyspepsia and other specified disorders of function of stomach | 5.45 | 7.33 | 1.09 | 3.07 | 4.66E-10 |
Other intestinal obstruction | 3.64 | 24.5 | 0.38 | 13 | 2.37E-06 |
Intestinal obstruction without mention of hernia | 3.64 | 27.5 | 0.82 | 9.96 | 7.98E-06 |
Irritable bowel syndrome | 3.64 | 7.5 | 1 | 3.84 | 9.57E-06 |
Dental | |||||
Gingival and periodontal diseases | 10.91 | 4.83 | 3 | 2.65 | 5.34E-10 |
Diseases of hard tissues of teeth | 43.64 | 5 | 11.93 | 4.72 | 2.47E-08 |
Disorders of tooth development | 12.73 | 3.57 | 5.75 | 2.42 | 4.51E-06 |
Diseases of pulp and periapical tissues | 5.45 | 4 | 1.33 | 2.67 | 5.92E-06 |
Disturbances in tooth eruption | 12.73 | 3.14 | 5.42 | 2.31 | 6.59E-06 |
Endocrine/metabolic | |||||
Short stature | 3.64 | 21.5 | 0.64 | 5.89 | 1.51E-17 |
Abnormal weight gain | 7.27 | 5 | 1.38 | 3.04 | 1.16E-08 |
Lack of normal physiological development | 27.27 | 7.93 | 2.58 | 7.74 | 1.24E-08 |
Hypokalemia | 9.09 | 7.2 | 1.53 | 5.6 | 4.05E-06 |
Electrolyte imbalance | 12.73 | 9 | 2.64 | 6.99 | 4.74E-05 |
Genitourinary | |||||
Retention of urine | 3.64 | 22 | 1.11 | 5.7 | 2.94E-09 |
Urinary incontinence | 20 | 7.09 | 2.93 | 6.23 | 1.01E-07 |
Other symptoms/disorders or the urinary system | 30.91 | 9.71 | 14.13 | 5.47 | 1.80E-07 |
Other conditions | |||||
Diseases of nail | 20 | 5.45 | 3.69 | 4.22 | 8.51E-11 |
Encounter for long-term (current) use of anticoagulants | 5.45 | 76 | 1.02 | 32.46 | 6.71E-07 |
Complication due to other implant and internal device | 3.64 | 5.5 | 0.55 | 3.1 | 1.26E-06 |
Cancer, suspected or other | 3.64 | 30 | 0.35 | 8.79 | 3.60E-12 |
Pleurisy; pleural effusion | 3.64 | 21 | 1.02 | 7.45 | 2.74E-05 |